Markers of NETs levels including cell-free DNA and myeloperoxidase-DNA were elevated in Behçet syndrome patients and DNAse treatment significantly decreased thrombin generation in Behçet syndrome plasm, indicated that inhibition of NETs may represent as a potential therapeutic target for Behçet syndrome [58]. Here, MPO is linked to Behcet disease.